Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 9

    1.

    Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy.

    Liu K, Jiang D, Zhang L, Yao Z, Chen Z, Yu S, Wang X.

    Vaccine. 2012 Apr 19;30(19):3034-41. Epub 2011 Oct 18.

    PMID:
    22008818
    [PubMed - in process]
    2.

    Of mice and not humans: how reliable are animal models for evaluation of herpes CD8(+)-T cell-epitopes-based immunotherapeutic vaccine candidates?

    Dasgupta G, BenMohamed L.

    Vaccine. 2011 Aug 11;29(35):5824-36. Epub 2011 Jun 28. Review.

    PMID:
    21718746
    [PubMed - indexed for MEDLINE]
    3.

    Effects of herpes simplex virus type 2 glycoprotein vaccines and CLDC adjuvant on genital herpes infection in the guinea pig.

    Bernstein DI, Earwood JD, Bravo FJ, Cohen GH, Eisenberg RJ, Clark JR, Fairman J, Cardin RD.

    Vaccine. 2011 Mar 3;29(11):2071-8. Epub 2011 Jan 14.

    PMID:
    21238569
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    An ocular mucosal administration of nanoparticles containing DNA vaccine pRSC-gD-IL-21 confers protection against mucosal challenge with herpes simplex virus type 1 in mice.

    Hu K, Dou J, Yu F, He X, Yuan X, Wang Y, Liu C, Gu N.

    Vaccine. 2011 Feb 4;29(7):1455-62. Epub 2010 Dec 24.

    PMID:
    21185849
    [PubMed - indexed for MEDLINE]
    5.

    A mucosal vaccination approach for herpes simplex virus type 2.

    Tirabassi RS, Ace CI, Levchenko T, Torchilin VP, Selin LK, Nie S, Guberski DL, Yang K.

    Vaccine. 2011 Jan 29;29(5):1090-8. Epub 2010 Dec 4.

    PMID:
    21134447
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    J-LEAPS vaccines initiate murine Th1 responses by activating dendritic cells.

    Taylor PR, Koski GK, Paustian CC, Bailey E, Cohen PA, Moore FB, Zimmerman DH, Rosenthal KS.

    Vaccine. 2010 Aug 2;28(34):5533-42. Epub 2010 Jun 25.

    PMID:
    20600501
    [PubMed - indexed for MEDLINE]
    7.

    Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice.

    Del Campo J, Lindqvist M, Cuello M, Bäckström M, Cabrerra O, Persson J, Perez O, Harandi AM.

    Vaccine. 2010 Feb 3;28(5):1193-200. Epub 2009 Nov 27.

    PMID:
    19945418
    [PubMed - indexed for MEDLINE]
    8.

    Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein.

    Reszka NJ, Dudek T, Knipe DM.

    Vaccine. 2010 Mar 24;28(15):2754-62. Epub 2010 Jan 29.

    PMID:
    20117270
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Liposomal gD ectodomain (gD1-306) vaccine protects against HSV2 genital or rectal infection of female and male mice.

    Olson K, Macias P, Hutton S, Ernst WA, Fujii G, Adler-Moore JP.

    Vaccine. 2009 Dec 11;28(2):548-60. Epub 2009 Oct 14.

    PMID:
    19835825
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk